Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Recursion Pharmaceuticals
RXRX
$1.78B
| $11.7M | ﹤0.01% |
1,190,882
+32,916
| +3% | +$235K |
|
1902
Tandem Diabetes Care
TNDM
$1.61B
| $11.7M | ﹤0.01% |
396,741
+29,730
| +8% | +$617K |
|
1903
nCino
NCNO
$2.26B
| $11.7M | ﹤0.01% |
347,058
+8,538
| +3% | +$254K |
|
1904
iShares Russell 1000 Value ETF
IWD
$84.3B
| $11.7M | ﹤0.01% |
70,539
-1,343
| -2% | -$207K |
|
1905
FB Financial Corp
FBK
$3.1B
| $11.6M | ﹤0.01% |
291,337
+12,443
| +4% | +$412K |
|
1906
National Bank Holdings
NBHC
$1.94B
| $11.6M | ﹤0.01% |
311,602
+13,554
| +5% | +$448K |
|
1907
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $11.6M | ﹤0.01% |
360,900
+17,046
| +5% | +$483K |
|
|
EVRI
1908
DELISTED
Everi Holdings
EVRI
| $11.5M | ﹤0.01% |
1,024,486
+58,267
| +6% | +$657K |
|
1909
Genesco
GCO
$394M
| $11.5M | ﹤0.01% |
327,616
+21,686
| +7% | +$667K |
|
1910
Ligand Pharmaceuticals
LGND
$5.76B
| $11.5M | ﹤0.01% |
161,480
+4,293
| +3% | +$253K |
|
1911
Hims & Hers Health
HIMS
$6.71B
| $11.5M | ﹤0.01% |
1,294,759
+22,009
| +2% | +$163K |
|
1912
Rocket Lab Corp
RKLB
$51.2B
| $11.5M | ﹤0.01% |
2,081,839
+24,232
| +1% | +$109K |
|
1913
Lucid Motors
LCID
$2.54B
| $11.5M | ﹤0.01% |
272,883
+19,552
| +8% | +$878K |
|
|
PRMW
1914
DELISTED
Primo Water Corporation
PRMW
| $11.5M | ﹤0.01% |
762,932
+8,173
| +1% | +$117K |
|
1915
XP
XP
$8.18B
| $11.4M | ﹤0.01% |
438,549
+72,987
| +20% | +$1.67M |
|
1916
Southside Bancshares
SBSI
$984M
| $11.4M | ﹤0.01% |
363,825
+15,470
| +4% | +$450K |
|
1917
Prothena Corp
PRTA
$466M
| $11.4M | ﹤0.01% |
313,230
+4,693
| +2% | +$181K |
|
1918
Alphatec Holdings
ATEC
$1.51B
| $11.3M | ﹤0.01% |
746,781
+125,488
| +20% | +$1.5M |
|
1919
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.95B
| $11.3M | ﹤0.01% |
415,279
+6,470
| +2% | +$170K |
|
1920
Ardelyx
ARDX
$1.01B
| $11.3M | ﹤0.01% |
1,816,732
+150,465
| +9% | +$675K |
|
|
WW
1921
DELISTED
WW International
WW
| $11.3M | ﹤0.01% |
1,286,957
-134,736
| -9% | -$1.14M |
|
1922
Gorman-Rupp
GRC
$2.11B
| $11.2M | ﹤0.01% |
316,457
+944
| +0.3% | +$30.4K |
|
|
GOGL
1923
DELISTED
Golden Ocean Group
GOGL
| $11.2M | ﹤0.01% |
1,151,274
+155,425
| +16% | +$1.29M |
|
1924
Unitil
UTL
$992M
| $11.2M | ﹤0.01% |
213,062
+9,489
| +5% | +$459K |
|
1925
Palomar
PLMR
$3.37B
| $11.2M | ﹤0.01% |
201,759
+5,897
| +3% | +$330K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.